Refinement of a Brief Anxiety Sensitivity Reduction Intervention
Refinement of a Brief Anxiety Sensitivity Reduction Intervention
复制标题
DOI：
10.1037/a0027961
复制
发表时间：
2012-10-01
影响因子：
5.9
通讯作者：
Schmidt, Norman B.
中科院分区：
文献类型：
--
作者：
Keough, Meghan E.;Schmidt, Norman B.
目的：焦虑症是美国最常见的精神疾病，给个人和社会造成了巨大的负担。虽然有效的治疗焦虑症已经开发出来，有相当少的关注干预措施，旨在改善焦虑相关的风险和维护因素。焦虑敏感性（AS）是惊恐障碍和其他精神病理学的一个公认的、可塑性的风险和维持因素。目前研究的目的是通过改进先前验证的干预措施来提高AS治疗的疗效。方法：这1个会话的干预利用心理教育和内感受性暴露于目标AS，并与健康为重点的控制干预之间的非寻求治疗的样本（N = 104）的个人与AS升高。结果如下：研究结果表明，在治疗后和整个1个月的研究期间，活性治疗组的AS降低幅度显著大于对照组。在ASI子量表中观察到这些治疗获益。第6个月随访评估表明，治疗组保留了大部分AS降低，而对照组保留了AS评分升高。符合轴I诊断标准的参与者的干预反应与当前未诊断的参与者的反应没有差异。结论：尽管治疗干预很简短，但研究结果表明，它导致AS大幅减少，并在治疗后6个月基本保持不变。焦虑的治疗和预防的影响进行了讨论。
Objective: Anxiety disorders are the most prevalent psychiatric disorders in the United States and result in substantial burden to the individual and society. Although effective treatments for anxiety disorders have been developed, there has been substantially less focus on interventions aimed at the amelioration of anxiety-related risk and maintenance factors. Anxiety sensitivity (AS) is a well-established, malleable risk and maintenance factor for panic disorder and other psychopathology. The aim of the current investigation was to enhance the efficacy of AS treatment through the refinement of a previously validated intervention. Method: This 1-session intervention utilized psychoeducation and interoceptive exposure to target AS and was compared with a health-focused control intervention among a nontreatment seeking sample (N = 104) of individuals with elevated AS. Results: Study findings indicate that the active treatment group demonstrated significantly greater reductions in AS than the control group at posttreatment and across the 1-month study period. These treatment gains were seen across the ASI subscales. A Month 6 follow-up assessment indicated that the treatment group retained the majority of their AS reduction, whereas the control group retained their elevated AS scores. The intervention responses of participants meeting Axis I diagnostic criteria did not differ from the responses of those without a current diagnosis. Conclusions: Despite the brevity of the treatment intervention, findings demonstrate that it resulted in substantial reductions in AS that were largely maintained 6 months posttreatment. Anxiety treatment and prevention implications are discussed.